Studies by Analysis Group Consultants Among 2023’s Most Cited Articles of the Journal of Managed Care & Specialty Pharmacy

February 26, 2024

Analysis Group consultants coauthored four studies on the Journal of Managed Care & Specialty Pharmacy’s list of its most cited articles of 2023. In the publishing list, the JMCP notes:

The most viewed and cited articles from 2023 are reflective of JMCP’s mission to advance science, expertise, and evidence-based decision making to improve patient health through access to high-quality, cost-effective medications and other therapies. The highlighted articles reflect the importance of cost effectiveness, interest in a range of common and rare diseases, and focus on drug pricing and coverage policy issues.

Analysis Group congratulates the following authors on their achievements:

Most cited (#1): Managing Principal Eric Q. Wu, Vice President Yan Song, and Manager Yanwen Xie, “Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States”

Most cited (#5): Managing Principal Noam Kirson and Vice Presidents Elyse Swallow and Debbie Goldschmidt, “Direct health care costs associated with COVID-19 in the United States”

Most cited (#6): Vice Presidents Wei Gao and Elyse Swallow, Manager Nicolae Done, and Associate Travis Wang, “All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States”

Most cited (#10): Managing Principals Annie Guérin and Patrick Lefebvre, Vice Presidents Patrick S. Gagnon and Martin Cloutier, and Senior Research Professionals Mikhaïl Davidson and Frédéric Kinkead, “Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: A societal perspective”